Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|April 23, 2011
Mesenchymal Stem Cells - Sources and Clinical ApplicationsHans Klingemann, David Matzilevich, James MarchandFrontiers in Immunology|March 26, 2016
Natural Killer Cells for Immunotherapy - Advantages of the NK-92 Cell Line over Blood NK CellsHans Klingemann, Laurent Boissel, Frances ToneguzzoLeukemia Research|January 17, 2009
Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cellsLaurent Boissel, Monica Betancur, Winfried S Wels, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cellsLaurent Boissel, Hande H Tuncer, Monica Betancur, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2007
Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantationRobb Friedman, Monica Betancur, Laurent Boissel, et al.Cytotherapy|April 11, 2022
CCR7 expression in CD19 chimeric antigen receptor-engineered natural killer cells improves migration toward CCL19-expressing lymphoma cells and increases tumor control in mice with human lymphomaNathan T Schomer, Ziyue Karen Jiang, Marit I Lloyd, et al.Leukemia & Lymphoma|June 30, 2009
Variable contribution of monoclonal antibodies to ADCC in patients with chronic lymphocytic leukemiaJames Weitzman, Monica Betancur, Laurent Boissel, et al.Blood|November 11, 2011
Distinct graft-versus-leukemic stem cell effects of early or delayed donor leukocyte infusions in a mouse chronic myeloid leukemia modelYi-Fen Lu, L Cristina Gavrilescu, Monica Betancur, et al.Leukemia & Lymphoma|October 26, 2011
Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigensLaurent Boissel, Monica Betancur, Weiquan Lu, et al.Journal of Cellular and Molecular Medicine|March 24, 2016
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignanciesAnnette Romanski, Christoph Uherek, Gesine Bug, et al.Pageof 3